743990
Last Update Posted: 2017-11-24
Recruiting has ended
All Genders accepted | 2 Years-11 Years |
143 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough
This study seeks to subjectively evaluate whether a single application of Vicks® VapoRub® (VVR) ointment or a control ointment (petrolatum) will be superior to no treatment for control of nocturnal cough and congestion due to upper respiratory tract infection (URI) as rated by both parents and children.
Eligibility
Relevant conditions:
Respiratory Tract Diseases
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov